PubMed Health⌕ Search

Biomedical subjects

G H Rong

Publications and source records attributed to G H Rong.

10 recordsLinked to original sources
PubMed1990

[Reduction mammoplasty using a modified "B" shape method].

This article presents a technique of reduction mammoplasty that is modified from the "B" operation for breast reduction devised by Dr Regnault. The overall excision line resembles the letter "B". The advantages of this technique are as followings: 1. It avoids incision in the so-called hypertrophic areas of the chest. 2. The patient has only a short curved scar (the medial horizontal branch of classic inverted-T incision is eliminated) that is not visible laterally. 3. Because there is no skin undermining, and the nipple is transposed on a upper semicircular dermal flap, so the blood supply of the nipple and areola is very good. 4. Ptotic and hypertrophic breasts can be treated with this method. 5. The resulting shape of the breast was satisfactory.

Breast↗
PubMed1987

Aberrant peripancreatic arterial anatomy. Considerations in performing pancreatectomy for malignant neoplasms.

One-hundred twenty patients with malignant neoplasms of the pancreas referred to the Surgery Branch of the National Cancer Institute over a 5-year period were prospectively examined with selective celiac and superior mesenteric angiography. Forty-one patients (34%) showed various arterial anomalies in the peripancreatic and hepatic areas. The most common anomalies included the right hepatic artery arising from the superior mesenteric artery (16%) and the left hepatic artery arising from the left gastric (11%). Thirty-two of the 120 patients eventually underwent pancreatic resection, and ten of the 32 resected patients (31%) had aberrant arterial anatomy. Recognition of the arterial anomalies permitted resection with no arterial reconstruction in nine of the patients. One patient required sacrifice of an aberrant right hepatic artery that was reconstructed with an anastomosis to the gastroduodenal artery remnant. Selective angiography should be done routinely before any potential radical resection for malignant neoplasms of the pancreas. Recognition of arterial anomalies generally permits satisfactory resection. Even if arterial segments require sacrifice, reconstruction can generally be accomplished with regional vessels, avoiding major arterial grafts.

Arteries↗
PubMed1986

Active immunotherapy of human solid tumor with autologous cells treated with cholesteryl hemisuccinate. A Phase I study.

A marked increase in specific immunogenicity of tumor cells is induced upon incorporation of cholesteryl hemisuccinate (CHS) into the cell membrane, which presumably promotes the expression of latent tumor-associated antigens. Immunotherapy with CHS-treated and irradiated tumor cells as vaccine was found to be very effective in various murine experimental tumors and in eliciting delayed-type hypersensitivity in cancer patients. Based on these findings, we have carried out a Phase I study on 21 patients with solid tumor who had exhausted standard therapeutic options. All participating patients were examined by conventional physical and clinical tests prior and during the study. The immunotherapy regimen for most patients consisted of an intramuscular injection of 2 X 10(7) CHS treated and irradiated autologous tumor cells given at 2-week intervals. Variations on this regimen were mostly due to the lack of sufficient number of cells. None of the patients displayed evidence of toxicity or any other local or systemic adverse effects. In seven patients, regression of tumor mass was observed. In six of nine patients who were tested for delayed-type hypersensitivity against their CHS treated tumor cells, a significant increase in skin reaction was observed after immunotherapy. The lack of any adverse reaction in this treatment, in addition to the observed positive clinical and immunologic response in advanced cancer patients, indicate a safe therapeutic potency which is planned to be investigated in the subsequent clinical studies.

Cholesterol Esters↗
PubMed1986

Inhibition of tumor angiogenesis by hexuronyl hexosaminoglycan sulfate.

The efficacy of heparin (HEP), the heparin analogue hexuronyl hexosaminoglycan sulfate (HHS), and hydrocortisone (HC) was studied in inhibiting the growth of four morphologically distinct pancreatic adenocarcinoma lines (CBP, LHP2, LSP3, and Pour-LVG) in hamsters. Animals were inoculated with LD100 doses of one of the four tumor lines and were randomly allocated to groups of five animals, which received in their drinking water either: HEP (1000 U/ml) alone, HHS (10 mg/ml) alone, HC (0.5 mg/ml) alone, HEP plus HC, HHS plus HC, or no additives (control). Tumors were measured, growth rates calculated, and nonparametric statistical comparisons made among the median growth rates of all of the treatment groups. All four tumors were tested in the rabbit cornea assay for their ability to induce angiogenesis. Extracts of tumors from control animals as well as from animals treated with HHS plus HC were prepared for quantitative testing in vitro by endothelial cell migration assay. All four tumor lines caused angiogenesis as measured in the rabbit cornea assay. A reduction in median tumor growth rates was observed in animals treated with HHS plus HC bearing the CBP, Pour-LVG, and LSP3 tumors. Similarly, in vitro capillary endothelial cell migration was decreased by HHS plus HC treatment in animals bearing CBP, Pour-LVG, and LSP3 tumors. Animals bearing the LHP2 tumor showed no effect of HHS plus HC treatment on tumor growth rate and no effect on endothelial cell migration. HEP alone, HHS alone, HC alone, and HEP plus HC showed no effect on tumor growth rate in any of the four tumors tested.

Animals↗
PubMed1986

Experiments evaluating antitumor immunity induced by cholesterol hemisuccinate-treated syngeneic cell vaccines.

Evaluation of the efficiency of immunizations with syngeneic tumor vaccines prepared from cells treated with cholesterol hemisuccinate (CHS) was performed in five animal models: P815 mastocytoma in DBA/2 mice, MCA-103 fibrosarcoma in C57BL/6N mice, L1210 leukemia in DBA/2 mice, Ehrlich ascites carcinoma in C57BL/6N mice, and CBP pancreatic cancer in CB/SsLak hamsters. Animals received two to four weekly intraperitoneal immunizations with 10(6) or 10(7) tumor cells, followed by challenges with syngeneic viable tumor cells. Survival and tumor growth rates were observed. No significant differences were observed among animals immunized with CHS-treated irradiated tumor vaccines, nontreated irradiated tumor vaccines, and nonimmunized controls in the P815, MCA-103, L1210, and CBP models. Mice immunized with nontreated irradiated Ehrlich ascites cell vaccines showed longer survival than those immunized with CHS-treated irradiated cell vaccines and nonimmunized controls. Results indicated that CHS-treated tumor cell vaccines were not effective in protecting against tumor challenges in five different syngeneic tumor models.

Animals↗
PubMed1986

Gastrointestinal carcinoma-associated antigen defined by a murine monoclonal antibody.

A murine monoclonal antibody, CHIP, has been prepared against a human pancreatic carcinoma cell line, SHAW. With the use of the avidin-biotin immunoperoxidase technique, the CHIP antibody detected an antigen found in 11 of 20 fixed tissue sections of tumors obtained from patients with pancreatic carcinoma. The antibody also detected the antigen in 25 of 26 colon carcinoma specimens, 4 of 6 gastric carcinoma specimens, and 1 of 2 esophageal adenocarcinoma specimens. The antigen was also found in normal proximal jejunum and colon and in small amounts in pancreatic islets and parathyroid. There was no reactivity with normal pancreatic ductal or acinar cells or with mesenchymal tissues.

Adenocarcinoma↗
PubMed1985

An enzymatic method for the consistent production of monodispersed viable cell suspensions from human solid tumors.

An enzymatic method is described for disaggregation of viable tumor cells from human solid tumors. The enzymatic cocktail consists of 0.1% collagenase, 0.01% hyaluronidase, and 0.002% deoxyribonuclease. After mechanical mincing of the tumor tissue, tumor specimens are dissociated by incubation in the enzymatic cocktail for 12-18 hours at room temperature. In 17 cases of sarcoma, the mean yield was 5 X 10(6) viable cells per gram tumor tissue. Yield was 1 X 10(7) viable cells per gram tumor tissue in 23 cases of gastrointestinal carcinoma. The viabilities of tumor cell suspensions ranged from 50 to 98%, except for low viabilities in four specimens that were grossly composed almost entirely of necrotic tissue. The dissociation procedure is simple and the viable cell yield is sufficient for applications in studies of human cancer immunobiology.

Cell Survival↗